Christy Arrowood

Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma

Cara M. Kenney, Tricia Kunst, Santhana Webb et al. · Investigational New Drugs · 2021 · 46 citations · Full text

Medicine, Oncology, Pharmacology +14

Preliminary results of a phase I study of bevacizumab (BV) in combination with everolimus (E) in patients with advanced solid tumors

Johanna C. Bendell, Joanne Lager, D. Yu et al. · Journal of Clinical Oncology · 2006 · 33 citations

Medicine, Oncology, Pharmacology +17

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

John H. Strickler, Shannon J. McCall, Andrew B. Nixon et al. · Investigational New Drugs · 2013 · 27 citations

Medicine, Oncology, Pharmacology +11

Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study

Kellen L. Meadows, Christel Rushing, Wanda Honeycutt et al. · Supportive Care in Cancer · 2014 · 25 citations · Full text

Pharmacy, Pharmacotherapy, Pain Management +3

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)

Jeffrey Clarke, Gerard C. Blobe, John H. Strickler et al. · Cancer Chemotherapy and Pharmacology · 2019 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17